Investigation of bioavailability, pharmacokinetics and safety of new pediatric formulations of artesunate and mefloquine

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 36, Issue 1, 2005, Pages 34-43

  Chanthap, L ^a   Tsuyuoka, R ^b   Na Bangchang, K ^c   Nivanna, N ^a   Suksom, D ^c   Sovannarith, T ^a   Socheat, D ^a  

^a Ministry of Health Cambodia   (Cambodia)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c THAMMASAT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; DIHYDROARTEMISININ; MEFLOQUINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CAMBODIA; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD CARE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RISK ASSESSMENT; SIDE EFFECT; SINGLE DRUG DOSE; SKIN MANIFESTATION;

EID: 17744398887     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Berman JG, Egan A, Keusch GT. The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg 2001; 64 (suppl): 4-7.
2. Bernakis A, Paris M, Loutan L, Plessas CT, Plessas ST. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am J Trop Med Hyg 1997; 56: 17-23.
3. Bunnag D, Kanda T, Karbwang J, Thimasarn K, Pungpak S, Harinasuta T. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1996; 90: 415-7.
4. Food and Drug Administration (FDA). FDA guidance: statistical procedures for bioequivalence studies using a standard two-treatment cross-over design. Washington DC: Food and Drug Administration, 1992.
5. th ed. Philadelphia : Lea and Febriger, 1989: 14-23.
6. Harinasuta T, Karbwang J. Qinghaosu: a promising antimalarial. JAMA SEA 1994; 3: 1994.
7. Hein TT. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Vietnam. Trans R Roc Trop Med Hyg 1994; 88 (Suppl): 7-8.
8. Karbwang J, White NJ. Clinical importance of antimalarial pharmacokinetics. Asia Pac J Pharmacol 1988; 3: 181.
9. Karbwang J, Back DJ, Bunnag D, Breckenridge AM. A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria. Eur J Clin Pharmacol 1988; 35: 677-80.
10. Karbwang J, Molunto P, Na-Bangchang K, Bunnag D. Determination of mefloquine in biological fluids by high performance liquid chromatography. Southeast Asian J Trop Med Public Health 1989; 20: 55-60.
11. Karbwang J, Na-Banchang K, Bunnag D, Harinasuta T. Pharmacokinetics and pharmacodynamics of mefloquine in patients with uncomplicated malaria. Bull WHO 1991a; 69: 207-12.
12. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Harinasuta T. Pharmacokinetics of mefloquine in treatment failure. Southeast Asian J Trop Med Public Health 1991b; 22: 523-6.
13. Karbwang J, Na-Bangchang K, Back DJ, Bunnag D. Effect of ampicillin on mefloquine pharmacokinetics in Thai males. Eur J Clin Pharmacol 1991c; 40: 631-3.
14. Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Harinasuta T. Pharmacokinetics of mefloquine in treatment failure. Southease Asian J Trop Med Public Health 1991d; 22: 523-6.
15. Karbwang J, Na-Bangchang K, Back DJ, Rooney W. Effect of tetracycline on mefloquine pharmacokinetics in Thai males. Eur J Clin Pharmacol 1992; 43: 567-9.
16. Karbwang J, Na-Bangchang K, Thimasarn K, Rooney W, Bunnag D, Harinasuta T. Mefloquine levels in patients with mefloquine resistant Plasmodium falciparum in the eastern part of Thailand. Southeast Asian J trop Med Public Health 1993; 24: 226-9
17. Karbwang J, Na-Bangchang K, Congpoung K, Thanavibul A, Harinasuta T. Pharmacokinetics of oral artesunate in Thai patients with uncomplicated falciparum malaria. Clin Drug Invest 1998; 15: 37-43.
18. Lobel HO, Miani M, Eng T, Bernhard KW, Hightower AW, Campbell CC. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848-51.
19. McGready R, Brockman A, Cho T, et al Randomised comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy. Trans R Soc Trop Med Hyg 2000; 94: 689-93.
20. Na-Bangchang K, Karbwang J, Back DJ. Effect of metoclopramide on mefloquine pharmacokinetics. Br J Clin Pharmacol 1991; 32: 640-1.
21. Na-Bangchang K, Molunto P, Banmairuroi V, Thanavibul A, Karbwang J. Pharmacokinetics of mefloquine when given as a single and two-divided dose regimens. Int J Clin Pharmacol Res 1995; XV: 215-20.
22. Na-Bangchang K, Karbwang J, Congpoung K, Thanavibul A, Ubalee R. Pharmacokinetic and bioequivalence evaluation of the two generic formulations of oral artesunate. Eur J Clin Pharmacol 1998a; 53: 375-6.
23. Na-Bangchang K, Congpoung K, Hung LN, Molunto P, Karbwang J. A simple high performance liquid chromatography with electrochemical detection for simultaneous determination of artesunate and dihydroartemisinin in biological fluids. J Chromatgr B 1998b; 708: 201-7.
24. Na-Bangchang K, Tippawangkosol P, Thanavibul A, Ubalee R, Karbwang J. Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartemisinin. Int J Clin Pharmacol Res 1999; XIX: 9-17.
25. Na-Bangchang K, Karbwang J, Palacois PAC, Ubalee R, Soenglertsilapachai S, Wernsdorfer WH. Pharmacokientics and bioequivalence evaluation of threee commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 2000; 55: 743-8.
26. Price RN, Nosten FF, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347: 1654-8.
27. Price RN, Nosten F, Luxemburger C, et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1998; 92: 122.
28. Sabcharoen A, Attanath P, Chanthavanich P, et al. Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria. Am J Trop Med Hyg 1998; 58: 11-6.
29. Ter Kuile FO, Nosten F, Thieren D, et al. High dose mefloquine in the treatment of multidrug resistant falciparum malaria. J Infect Dis 1992; 166: 1393-400.
30. Thimasarn K, Sirichaisinthop J, Chanyakhun P, Palananth C, Rooney W. A comparative study of artesunate and artemether in combination with mefloquine on multidrug resistant falciparum malaria in eastern Thailand. Southeast Asian J Trop Med Public Health 1997; 28: 465-71.
31. Weidekamm E, Rusing G, Caplain H, Sorgel F, Crevoisier C. Lack of bioequivalence of a generic mefloquine tablet with the standard product. Eur J Clin Pharmacol 1998; 54: 615-9.
32. White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother 1997; 41: 1413-22.